(21412778), L. H., (1766401), Y. X., (102929), N. L., (436622), H. C., (12735888), Z. W., (14032517), Q. L., . . . (14032511), Z. L. (2025). Data Sheet 1_Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.docx.
Chicago Style (17th ed.) Citation(21412778), Lichang Huang, et al. Data Sheet 1_Lenvatinib Versus Bevacizumab When Combined with PD-1/L1 Inhibitor and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma.docx. 2025.
MLA (9th ed.) Citation(21412778), Lichang Huang, et al. Data Sheet 1_Lenvatinib Versus Bevacizumab When Combined with PD-1/L1 Inhibitor and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma.docx. 2025.